In the scenario where CCRCC serves as the recipient tumor, due to the inactivation of the von Hippel-Lindau (VHL) gene in CCRCC, hypoxia-inducible factor (HIF) is overexpressed abnormally. This evidence concerns the gene VHL and neoplasm.